Circulating and Endometrial Tissue microRNA Markers Associated with Endometrial Cancer Diagnosis, Prognosis, and Response to Treatment
In developed countries, endometrial cancer (EC) is one of the most common neoplasms of the female reproductive system. MicroRNAs (miRs) are a class of single-stranded noncoding RNA molecules with lengths of 19–25 nucleotides that bind to target messenger RNA (mRNA) to regulate post-transcriptional g...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-05-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/10/2686 |
_version_ | 1797600705463189504 |
---|---|
author | Sergio Antonio Oropeza-de Lara Idalia Garza-Veloz Bertha Berthaud-González Margarita L. Martinez-Fierro |
author_facet | Sergio Antonio Oropeza-de Lara Idalia Garza-Veloz Bertha Berthaud-González Margarita L. Martinez-Fierro |
author_sort | Sergio Antonio Oropeza-de Lara |
collection | DOAJ |
description | In developed countries, endometrial cancer (EC) is one of the most common neoplasms of the female reproductive system. MicroRNAs (miRs) are a class of single-stranded noncoding RNA molecules with lengths of 19–25 nucleotides that bind to target messenger RNA (mRNA) to regulate post-transcriptional gene expression. Although there is a large amount of research focused on identifying miRs with a diagnostic, prognostic, or response to treatment capacity in EC, these studies differ in terms of experimental methodology, types of samples used, selection criteria, and results obtained. Hence, there is a large amount of heterogeneous information that makes it difficult to identify potential miR biomarkers. We aimed to summarize the current knowledge on miRs that have been shown to be the most suitable potential markers for EC. We searched PubMed and Google Scholar without date restrictions or filters. We described 138 miRs with potential diagnostic, prognostic, or treatment response potential in EC. Seven diagnostic panels showed higher sensitivity and specificity for the diagnosis of EC than individual miRs. We further identified miRs up- or downregulated depending on the FIGO stage, precursor lesions, and staging after surgery, which provides insight into which miRs are expressed chronologically depending on the disease stage and/or that are modulated depending on the tumor grade based on histopathological evaluation. |
first_indexed | 2024-03-11T03:52:41Z |
format | Article |
id | doaj.art-5ef33fc6916849e78f753560eef630e5 |
institution | Directory Open Access Journal |
issn | 2072-6694 |
language | English |
last_indexed | 2024-03-11T03:52:41Z |
publishDate | 2023-05-01 |
publisher | MDPI AG |
record_format | Article |
series | Cancers |
spelling | doaj.art-5ef33fc6916849e78f753560eef630e52023-11-18T00:47:30ZengMDPI AGCancers2072-66942023-05-011510268610.3390/cancers15102686Circulating and Endometrial Tissue microRNA Markers Associated with Endometrial Cancer Diagnosis, Prognosis, and Response to TreatmentSergio Antonio Oropeza-de Lara0Idalia Garza-Veloz1Bertha Berthaud-González2Margarita L. Martinez-Fierro3Molecular Medicine Laboratory, Academic Unit of Human Medicine and Health Sciences, Universidad Autónoma de Zacatecas, Carretera Zacatecas-Guadalajara Km 6, Ejido La Escondida, Zacatecas 98160, MexicoMolecular Medicine Laboratory, Academic Unit of Human Medicine and Health Sciences, Universidad Autónoma de Zacatecas, Carretera Zacatecas-Guadalajara Km 6, Ejido La Escondida, Zacatecas 98160, MexicoHospital General Zacatecas “Luz González Cosío”, Servicios de Salud de Zacatecas, Zacatecas 98160, MexicoMolecular Medicine Laboratory, Academic Unit of Human Medicine and Health Sciences, Universidad Autónoma de Zacatecas, Carretera Zacatecas-Guadalajara Km 6, Ejido La Escondida, Zacatecas 98160, MexicoIn developed countries, endometrial cancer (EC) is one of the most common neoplasms of the female reproductive system. MicroRNAs (miRs) are a class of single-stranded noncoding RNA molecules with lengths of 19–25 nucleotides that bind to target messenger RNA (mRNA) to regulate post-transcriptional gene expression. Although there is a large amount of research focused on identifying miRs with a diagnostic, prognostic, or response to treatment capacity in EC, these studies differ in terms of experimental methodology, types of samples used, selection criteria, and results obtained. Hence, there is a large amount of heterogeneous information that makes it difficult to identify potential miR biomarkers. We aimed to summarize the current knowledge on miRs that have been shown to be the most suitable potential markers for EC. We searched PubMed and Google Scholar without date restrictions or filters. We described 138 miRs with potential diagnostic, prognostic, or treatment response potential in EC. Seven diagnostic panels showed higher sensitivity and specificity for the diagnosis of EC than individual miRs. We further identified miRs up- or downregulated depending on the FIGO stage, precursor lesions, and staging after surgery, which provides insight into which miRs are expressed chronologically depending on the disease stage and/or that are modulated depending on the tumor grade based on histopathological evaluation.https://www.mdpi.com/2072-6694/15/10/2686endometrial cancermiRNAsbiomarkersdiagnosisprognosisresponse to treatment |
spellingShingle | Sergio Antonio Oropeza-de Lara Idalia Garza-Veloz Bertha Berthaud-González Margarita L. Martinez-Fierro Circulating and Endometrial Tissue microRNA Markers Associated with Endometrial Cancer Diagnosis, Prognosis, and Response to Treatment Cancers endometrial cancer miRNAs biomarkers diagnosis prognosis response to treatment |
title | Circulating and Endometrial Tissue microRNA Markers Associated with Endometrial Cancer Diagnosis, Prognosis, and Response to Treatment |
title_full | Circulating and Endometrial Tissue microRNA Markers Associated with Endometrial Cancer Diagnosis, Prognosis, and Response to Treatment |
title_fullStr | Circulating and Endometrial Tissue microRNA Markers Associated with Endometrial Cancer Diagnosis, Prognosis, and Response to Treatment |
title_full_unstemmed | Circulating and Endometrial Tissue microRNA Markers Associated with Endometrial Cancer Diagnosis, Prognosis, and Response to Treatment |
title_short | Circulating and Endometrial Tissue microRNA Markers Associated with Endometrial Cancer Diagnosis, Prognosis, and Response to Treatment |
title_sort | circulating and endometrial tissue microrna markers associated with endometrial cancer diagnosis prognosis and response to treatment |
topic | endometrial cancer miRNAs biomarkers diagnosis prognosis response to treatment |
url | https://www.mdpi.com/2072-6694/15/10/2686 |
work_keys_str_mv | AT sergioantoniooropezadelara circulatingandendometrialtissuemicrornamarkersassociatedwithendometrialcancerdiagnosisprognosisandresponsetotreatment AT idaliagarzaveloz circulatingandendometrialtissuemicrornamarkersassociatedwithendometrialcancerdiagnosisprognosisandresponsetotreatment AT berthaberthaudgonzalez circulatingandendometrialtissuemicrornamarkersassociatedwithendometrialcancerdiagnosisprognosisandresponsetotreatment AT margaritalmartinezfierro circulatingandendometrialtissuemicrornamarkersassociatedwithendometrialcancerdiagnosisprognosisandresponsetotreatment |